Cargando…

Benefit of a Short Chain Peptide as a Targeting Ligand of Nanocarriers for a Brain-Driven Purpose

Treatment of glioma remains a critical challenge worldwide, since the therapeutic effect is greatly hindered by poor transportation across the blood brain barrier (BBB) and low penetration into tumor cells. In this study, a peptide-conjugated nano-delivery system was explored for the purpose of glio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Yu-Chen, Lin, Wen-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401212/
https://www.ncbi.nlm.nih.gov/pubmed/34452209
http://dx.doi.org/10.3390/pharmaceutics13081249